What is Alkermes's EBITDA margin?

Alkermes (ALKS) reported EBITDA margin of 14.8% in Q1 2026.

How has Alkermes's EBITDA margin changed year-over-year?

Alkermes's EBITDA margin decreased by 46.6% year-over-year, from 27.7% to 14.8%.

What is the long-term trend for Alkermes's EBITDA margin?

Over 4 years (2020 to 2025), Alkermes's EBITDA margin has grown at a 59.5% compound annual growth rate (CAGR), from -2.9% to 19%.

Alkermes ALKS EBITDA margin

EBITDA margin at other companies

Bristol-Myers SquibbBMY

27.2%-2.2pp

Jazz PharmaceuticalsJAZZ

-10.9%-28.0pp

AbbVieABBV

37.3%—

Axsome TherapeuticsAXSM

-23.5%-8.9pp

Ionis PharmaceuticalsIONS

-32%-10.7pp

Neurocrine BiosciencesNBIX

26.4%+4.7pp

Other financials

Income statement

See full

Revenue$392.9M+28.2%

Gross profit$331.3M+28.8%

Operating income-$48.3M-450%

Net income-$66.5M-396%

EPS (diluted)-$0.40-408%

Balance sheet

See full

Cash & equivalents$351.6M-12.1%

Total debt$1.6B+2,034%

Total equity$1.8B+15.9%

Total assets$4.3B+105%

Cash flow

See full

Operating cash flow-$165.7M-268%

CapEx$4.1M-59.5%

Free cash flow-$169.8M-291%

Valuation

See full

Market cap$7.5B+9.7%

Enterprise value$8.73B+41.2%

P/E49.1×+29.7×

P/S4.8×+0.3×

Profitability

See full

Gross margin86.6%+2.2pp

Operating margin12.3%-13.6pp

Net margin9.8%-13.5pp

FCF margin14.2%-17.6pp

Returns & leverage

See full

Return on equity9.4%-16.1pp

Debt / equity0.9×+0.9×

Current ratio2.3×-1.1×

Where this comes from

Calculated from Alkermes’s reported figures.

ebitda/total revenue=14.8%

Based on trailing twelve months.

The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alkermes's EBITDA margin?: Alkermes (ALKS) reported EBITDA margin of 14.8% in Q1 2026.
How has Alkermes's EBITDA margin changed year-over-year?: Alkermes's EBITDA margin decreased by 46.6% year-over-year, from 27.7% to 14.8%.
What is the long-term trend for Alkermes's EBITDA margin?: Over 4 years (2020 to 2025), Alkermes's EBITDA margin has grown at a 59.5% compound annual growth rate (CAGR), from -2.9% to 19%.